Georges Této

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

Désiré Takou, Joseph Fokam, Georges Této et al. · BMC Infectious Diseases · 2019 · 35 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals

Alex Durand Nka, Yagaï Bouba, Georges Této et al. · Journal of Antimicrobial Chemotherapy · 2022 · 27 citations

Life Sciences, Molecular Genetics, Pharmacology +17

Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon

Georges Této, Georgette D. Kanmogne, Judith Torimiro et al. · PLoS ONE · 2013 · 25 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé

Alex Durand Nka, Samuel Martin Sosso, Joseph Fokam et al. · BMC Research Notes · 2019 · 25 citations · Full text

Medicine, Hematology, Infectious Diseases +11

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings

Ezéchiel Ngoufack Jagni Semengue, Daniele Armenia, Seth Inzaule et al. · Journal of Antimicrobial Chemotherapy · 2021 · 25 citations · Full text

Life Sciences, Microbiology, Pharmacotherapy +17